Építés alatt – nem éles oldal
Belépés

Tripla negatív emlőrák trials, also abroad

476 open Tripla negatív emlőrák trials worldwide. Travel and costs are your own unless the study pays them; ask the study team first.

OrszágOpen trials
Egyesült Államok171
Kína133
Franciaország43
Spanyolország33
Ausztrália31
All other countries

The same trial often runs in several countries

A Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) as Monotherapy and in Combination With Pembrolizumab (MK-3475) in Participants With Triple-Negative Breast Cancer (MK-2870-011/TroFuse-011) has 7 sites in Hollandia and runs in 35 countries. If a site near you is full, another one may still take people.

See A Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) as Monotherapy and in Combination With Pembrolizumab (MK-3475) in Participants With Triple-Negative Breast Cancer (MK-2870-011/TroFuse-011) in all 35 countries
Építés alatt, nem éles – Tripla negatív emlőrák: vizsgálatok itt: Hollandia – Frontlight Research